NCT00662233
- Conditions
- Adnexal Diseases, Desmoplastic Small Round Cell Tumor, Endocrine Gland Neoplasms, +17 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Adnexal Diseases
Explore clinical trials studying Adnexal Diseases. Study availability and eligibility vary by location and protocol.
3,513 public trials
681 recruiting studies
Adnexal Diseases trial results
NCT00410553
- Conditions
- Adnexal Diseases, Adult Solid Neoplasm, Endocrine Gland Neoplasms, +19 more
- Locations
-
- Ottawa Hospital-Civic Campus Ottawa, Ontario, Canada
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
NCT02869750
- Conditions
- Adnexal Diseases, Cysts, Endocrine System Diseases, +11 more
- Locations
-
- Ahmed Kotb Cairo, Cairo Governorate, Egypt
NCT00030706
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +18 more
- Locations
-
- Albert Einstein Cancer Center at Albert Einstein College of Medicine The Bronx, New York, United States
Completed
Phase II Study of NGR-hTNF in Combination With Doxorubicin in Platinum-resistant Ovarian Cancer
NCT01358071
- Conditions
- Adnexal Diseases, Disease Attributes, Disease Progression, +19 more
- Locations
-
- Ospedale San Raffaele Milan, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
- Istituto Europeo di Oncologia Milan, Italy
- Istituto Nazionale Tumori IRCCS Fondazione "Giovanni Pascale" Naples, Italy
NCT00484432
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Fondazione San Raffaele del Monte Tabor Milan, Italy
- Policlinico Universitario A. Gemelli Rome, Italy
NCT01863693
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Royal United Hospital; Oncology Department Bath, United Kingdom
- City Hospital Birmingham, United Kingdom
- Bradford Royal Infirmary; Oncology Department Bradford, United Kingdom
- Bristol Haematology and Oncology Centre Bristol, United Kingdom
Completed
A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer
NCT00281632
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
- Locations
-
- GSK Investigational Site Atlanta, Georgia, United States
- GSK Investigational Site Austin, Texas, United States
- GSK Investigational Site Bedford, Texas, United States
- GSK Investigational Site Dallas, Texas, United States
NCT01544049
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- University of Washington Seattle, Washington, United States
NCT02046421
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +31 more
- Locations
-
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- NorthShore University HealthSystem Evanston, Illinois, United States